MRI examination of the breast in the context of BI-RADS 3 findings requiring control 6 months after initial pre-operative breast MRI

MRI examination of the breast in the context of BI-RADS 3 findings requiring control 6 months after initial pre-operative breast MRI - Ma-MRT_MagTrace

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00030512

Enrollment

Registered

2022-10-13

Start date

2023-01-11

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C50

Interventions

Group 1: MRI examination of the breast in the context of BI-RADS 3 findings requiring control 6 months after initial pre-operative breast MRI.

Eligibility

Sex/Gender

Female

Age

50 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Punch biopsy confirmed unifocal breast carcinoma, - Age >50 years, - Written informed consent of the patient.

Exclusion criteria

Exclusion criteria: - Multifocal or bilateral breast carcinoma, - Hereditary breast carcinoma, such as BRCA1/2, - Contrast agent allergy, - Contraindication for MRI.

Design outcomes

Primary

Measure	Time frame
Analysis of the diagnostic value of mammary MRI 6 Monte after insertion of the paramagnetic particles for sentinel lymph node labeling, and assessability of the axilla.	—

Secondary

Measure	Time frame
Opportunities to reduce susceptibility artifacts using specialized MRI sequences, such as WARP.	—

Countries

Germany

Contacts

Public ContactMarkus Hahn

Universitätsklinikum Tübingen, Frauenklinik

markus.hahn@med.uni-tuebingen.de07071-2964117

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026